INCB-59872

N/A

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameINCB-59872
Drug Alias NameINCB-59872INCB-059872
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsSolid tumoursMyelodysplastic-Myeloproliferative DiseasesAnemia, Sickle Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesIncyte Corp
Inactive CompaniesN/A
Active IndicationsMyelodysplastic-Myeloproliferative Diseases
Inactive IndicationsSolid tumoursAnemia, Sickle CellSarcoma, Ewing

Other Information

ATC CodeN/A
Related LinksN/A